| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |